Demir Mustafa, Bölük S E, Sücüllü I, Güleç B, Bölük S
Nazilli State Hospital, Aydın, Turkey.
Istanbul Sultan Abdulhamid Han Training And Research Hospital, Uskudar, Istanbul, 34668, Turkey.
Tech Coloproctol. 2025 May 6;29(1):109. doi: 10.1007/s10151-025-03143-1.
Pilonidal sinus is a frequently observed disease in young adult male patients. Although its treatment is traditionally surgical, the tendency to use minimally invasive interventions has increased over time. This study aims to compare the clinical results of the non-surgical treatment methods for pilonidal sinus: crystallized and liquid phenol applications.
We retrospectively analyzed the data of 102 patients treated with phenol application in the General Surgery Clinic of our hospital between July 2017 and July 2019. Eighty patients were included in the study: 40 treated with crystallized phenol and 40 with liquid phenol. In the 1st month following the application, the recovery rates, complication rates, persistence of complaints, and recurrence at the end of the 1st year were compared between the groups.
The mean age was 25.60 ± 7.16 and 25.78 ± 7.83 years in the crystallized (group 1) and liquid phenol group (group 2), respectively. Complications observed up to the 3rd week of follow-up were considered early complications, while those observed after the 3rd week were considered late complications. Early complications were observed in 15% and 37.5% of patients in groups 1 and 2, respectively (p = 0.042). Early complications were significantly higher in the liquid phenol group compared to the crystallized phenol group. At the end of the 1st year, 90% improvement was detected in group 1 and 95% in group 2. However, there was no significant difference between the recovery and recurrence rates between the groups.
In pilonidal sinus treatment, successful results are obtained with both crystallized and liquid phenol application. Both methods can be performed safely and easily as an alternative treatment method to surgery.
藏毛窦是年轻成年男性患者中常见的疾病。虽然其传统治疗方法是手术,但随着时间的推移,使用微创干预的趋势有所增加。本研究旨在比较藏毛窦非手术治疗方法(结晶酚和液体酚应用)的临床结果。
我们回顾性分析了2017年7月至2019年7月在我院普通外科门诊接受酚治疗的102例患者的数据。80例患者纳入研究:40例接受结晶酚治疗,40例接受液体酚治疗。在应用后的第1个月,比较两组之间的恢复率、并发症发生率、症状持续情况以及第1年末的复发情况。
结晶酚组(第1组)和液体酚组(第2组)的平均年龄分别为25.60±7.16岁和25.78±7.83岁。随访至第3周观察到的并发症被视为早期并发症,而第3周后观察到的并发症被视为晚期并发症。第1组和第2组分别有15%和37.5%的患者出现早期并发症(p = 0.042)。液体酚组的早期并发症明显高于结晶酚组。在第1年末,第1组检测到90%的改善,第2组为95%。然而,两组之间的恢复率和复发率没有显著差异。
在藏毛窦治疗中,结晶酚和液体酚应用均取得了成功的结果。作为手术的替代治疗方法,这两种方法都可以安全、轻松地进行。